{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T01:19:36Z","timestamp":1712020776290},"reference-count":0,"publisher":"The Medical Letter, Inc.","issue":"1700","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Lett Drugs Ther"],"abstract":"<jats:p>The FDA has approved Cabtreo (Bausch Health), a gel containing the retinoid adapalene, the oxidizing agent benzoyl peroxide, and the antibiotic clindamycin, for treatment of acne vulgaris in patients \u226512 years old. Cabtreo is the first three-drug topical formulation to become available in the US for treatment of acne.<\/jats:p>","DOI":"10.58347\/tml.2024.1700b","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T17:22:21Z","timestamp":1711992141000},"page":"59-60","source":"Crossref","is-referenced-by-count":0,"title":["Cabtreo: A Three-Drug Gel for Acne"],"prefix":"10.58347","volume":"66","author":[{"name":"Editors from The Medical Letter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37151","published-online":{"date-parts":[[2024,4,15]]},"container-title":["The Medical Letter on Drugs and Therapeutics"],"original-title":[],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T17:22:21Z","timestamp":1711992141000},"score":1,"resource":{"primary":{"URL":"https:\/\/secure.medicalletter.org\/TML-article-1700b"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":0,"journal-issue":{"issue":"1700","published-online":{"date-parts":[[2024,4,15]]}},"URL":"https:\/\/doi.org\/10.58347\/tml.2024.1700b","relation":{},"ISSN":["1523-2859"],"issn-type":[{"value":"1523-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]}}}